Strictly Laboratory Research Use Only: Not approved for human or clinical consumption. HPLC Purity Tested (≥99%).

Purity:

MITO PRIME — MAXIMUM ENERGY

Vial Size / Concentration: 

$70.00

/ vial

Advanced Mitochondrial & Cellular-Energy Research Protocol

Mito Prime combines three compounds studied across complementary areas of mitochondrial biology: SS-31, MOTS-C, and NAD+. The research concept is designed around multiple stages of cellular energy production—from mitochondrial membrane integrity and metabolic signaling to the biochemical reactions that ultimately support ATP production.

SS-31 is a mitochondria-targeted peptide studied for its interaction with cardiolipin, a phospholipid of the inner mitochondrial membrane. Research focuses on mitochondrial membrane stability, electron-transport-chain function, oxidative stress, and cellular energetics.

MOTS-C is a mitochondrial-derived peptide investigated for its role in metabolic signaling, AMPK-associated pathways, glucose utilization, and cellular adaptation to energetic stress.

NAD+ is an essential cellular coenzyme involved in redox reactions, mitochondrial energy metabolism, DNA-repair pathways, and cellular signaling. Its NAD+/NADH cycling plays a central role in transferring electrons during energy production.

Together, Mito Prime provides researchers with a multi-compound platform for investigating how mitochondrial integrity, metabolic signaling, electron transfer, and ATP-related energy pathways interact.

Research Focus: Mitochondrial Function • Cellular Energy & ATP Pathways • Cardiolipin • AMPK Signaling • NAD+ Metabolism • Metabolic Research • Oxidative-Stress Research

Complete Mito Prime Kit: SS-31 10 mg — 9 vials MOTS-C 10 mg — 6 vials NAD+ 500 mg — 6 vials

21 Total Vials

RESEARCH USE ONLY NOT FOR HUMAN OR ANIMAL USE

CAS Number:

Molecular Formula:

Molecular Weight:

Appearance:

ISO 9001:2015 Verified Laboratory Compound

Submit Research Specification

All synthesis requests are handled under rigorous laboratory non-disclosure agreements.